A minute ago
- copy link
According to the latest report, Public Health England, a UK health organization, till 7 June, 6 cases of the Delta + variant had been reported in India. The photo is of a staff posted at a hospital in Bangalore.
The Delta variant, which caused havoc in the country in the second wave of Corona, has now turned into the more dangerous Delta+. Scientists fear that the monoclonal antibodies cocktail being given to corona patients may be neutralized on this variant. The monoclonal antibodies cocktail was approved for emergency use in the country in early May.
According to the UK health organization Public Health England (PHE), 63 genomes of the delta variant have been revealed with the new K417N mutation. According to the PHE, the Delta+ has been detected during a routine check of changes in the Delta variant. According to the latest PHE report on Kovid variants, 6 cases of Delta+ variant were reported in India till June 7.
Dr. Vinod Skaria of Delhi’s Institute of Genomics and Integrative Biology says that the key concern about the K417N mutation is the evidence that it is resistant to the antibody cocktail. However, he also says that the frequency of K417N mutation is not very high in India.
What is Monoclonal Antibodies Cocktail?
The monoclonal antibodies cocktail is composed of casirivimab and imdevimab. It has been made jointly by the pharma company Cipla and Roche India. In India, it was approved in May for emergency use for the treatment of corona. It received approval from the Central Drugs Standards Control Organization (CDSCO) on the basis of data provided for emergency use in the US and the European Union.